BLOG / 🇺🇸 United States · · daily

All HHS Contracts — July 31, 2026

All HHS Contracts

By Gunpowder Editorial ·

1 total filings analysed

Executive Summary

The sole contract in this digest is a $173.3 million cost-plus-fixed-fee award from the National Institutes of Health (NIH) to Technical Resources International, Inc. for clinical research operations and management support (CROMS), spanning 2017-2026. This is a purely civilian award with no defense-related content, underscoring NIH's sustained investment in health R&D services.

The highest-conviction signal is the low pricing risk and long-term revenue stability afforded by the cost-plus structure, providing predictable margins for a small business. Key watch items include potential contract modifications or extensions beyond July 2026 and the company's ability to scale operations given its small business status.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Tracking the trend? Catch up on the prior All HHS Contracts digest from July 24, 2026.

Investment Signals (1)

  • Technical Resources International Secures $173.3M NIH CROMS Contract, Ensuring Long-Term Revenue Stability (HIGH)

    The cost-plus-fixed-fee structure mitigates pricing risk, providing predictable margins over a 9.3-year performance period, with annual revenue estimated at $18.6 million. The full-and-open competition win signals competitive merit, and the company's small, woman-owned, Hispanic American-owned status may offer future contracting advantages.

Risk Flags (2)

  • Concentration [MEDIUM RISK]

    Technical Resources International has a significant revenue concentration risk, with this single NIH contract representing the entirety of the analyzed award value. The contract's long duration (2017-2026) reduces near-term re-compete risk, but the company's dependence on NIH as a sole client could be a vulnerability if future NIH funding is constrained.

  • Execution [LOW RISK]

    As a small business, Technical Resources International may face challenges scaling operations to meet the demands of a $173.3 million contract, potentially impacting performance quality and future re-compete opportunities.

Opportunities (2)

  • The NIH CROMS contract positions Technical Resources International for potential follow-on work in clinical research support, given its proven track record and small business set-aside advantages. The company could leverage this experience to bid on other NIH or HHS health R&D contracts.

  • Technical Resources International's status as a woman-owned and Hispanic American-owned small business may provide eligibility for set-aside contracts, offering a competitive edge in future federal procurements beyond NIH.

Sector Themes (1)

  • The $173.3 million award to Technical Resources International underscores NIH's consistent funding for clinical research operations and management support, a stable segment within the broader health R&D services market.

Watch List (2)

  • 👁

    {"entity" => "Technical Resources International, Inc.", "reason" => "The company's performance on this $173.3 million NIH contract will be critical for future re-competes and potential expansion into other HHS agencies.", "trigger" => "Contract extension or modification announcement, or new NIH task order awards"}

  • 👁

    {"entity" => "NIH", "reason" => "NIH's budget trajectory and procurement patterns for clinical research support will directly impact Technical Resources International and the broader sector.", "trigger" => "FY2027 budget request, potential Continuing Resolution impacts, or new CROMS re-compete announcements"}

Get daily alerts with 1 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 1 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: All HHS Contracts

🇺🇸 More from United States

View all →